Sinphar Pharmaceutical Co., Ltd. (1734)
Market Closed
11 Jun, 05:30
TWSE TWSE Primary NT$
31. 10
-0.2
-0.639%
NT$
5.92B Market Cap
13.52 P/E Ratio
3.81% Div Yield
227,804 Volume
4.68 Eps
NT$ 31.3
Previous Close Want to track 1734 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | 0.43 | - |
| | | 0.43 | 0.62 |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | 0.4 |
| | | 0.32 | - |
| | | - | - |
| | | - | - |
| | | - | 0.32 |
| | | - | - |
| | | - | 0.42 |
| | | - | 0.36 |
| | | - | 0.19 |
| | | - | 0.53 |
| | | - | 0.35 |
| | | - | 0.72 |
| | | - | 0.04 |
1734 Earnings Reports FAQ
What is the earnings per share (EPS) for 1734?
The current EPS is 4.68.
What is the company's earnings growth rate?
Over the past 13 years, the earnings growth rate has been approximately 25.74%, reflecting the 1734's performance and TWSE market conditions.
When is the next earnings release date?
Sinphar Pharmaceutical Co., Ltd has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Sinphar Pharmaceutical Co., Ltd are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 1734 at this time, as Sinphar Pharmaceutical Co., Ltd has no recent EPS data to calculate it.
